Novo, Pfizer Square Off Over Metsera in Obesity-Drug Tussle
Published on November 3, 2025
Novo Nordisk A/S made an unsolicited bid for US biotech firm Metsera Inc., sparking a heated battle with Pfizer Inc. to get their hands on weight-loss treatments that both drugmakers want in order to regain lost ground in the booming market.